vs
Arcosa, Inc.（ACA）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Arcosa, Inc.的季度营收约是Royalty Pharma plc的1.2倍（$716.7M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 7.3%，领先27.2%），Arcosa, Inc.同比增速更快（7.6% vs 4.8%），过去两年Arcosa, Inc.的营收复合增速更高（9.4% vs 4.6%）
Arcosa, Inc.是一家基础设施相关产品及解决方案提供商，业务覆盖建筑、能源、交通三大核心板块，主营公用设施结构件、建筑集料、交通零部件等产品，主要面向北美市场客户，为各类关键基础设施建设项目提供支持。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ACA vs RPRX — 直观对比
营收规模更大
ACA
是对方的1.2倍
$622.0M
营收增速更快
ACA
高出2.8%
4.8%
净利率更高
RPRX
高出27.2%
7.3%
两年增速更快
ACA
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $716.7M | $622.0M |
| 净利润 | $52.1M | $214.2M |
| 毛利率 | 22.9% | — |
| 营业利润率 | 11.0% | 62.4% |
| 净利率 | 7.3% | 34.4% |
| 营收同比 | 7.6% | 4.8% |
| 净利润同比 | 776.6% | 2.9% |
| 每股收益（稀释后） | $1.06 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACARPRX
| Q4 25 | $716.7M | $622.0M | ||
| Q3 25 | $797.8M | $609.3M | ||
| Q2 25 | $736.9M | $578.7M | ||
| Q1 25 | $632.0M | $568.2M | ||
| Q4 24 | $666.2M | $593.6M | ||
| Q3 24 | $640.4M | $564.7M | ||
| Q2 24 | $664.7M | $537.3M | ||
| Q1 24 | $598.6M | $568.0M |
净利润ACARPRX
| Q4 25 | $52.1M | $214.2M | ||
| Q3 25 | $73.0M | $288.2M | ||
| Q2 25 | $59.7M | $30.2M | ||
| Q1 25 | $23.6M | $238.3M | ||
| Q4 24 | $-7.7M | $208.2M | ||
| Q3 24 | $16.6M | $544.0M | ||
| Q2 24 | $45.6M | $102.0M | ||
| Q1 24 | $39.2M | $4.8M |
毛利率ACARPRX
| Q4 25 | 22.9% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 22.5% | — | ||
| Q1 25 | 19.8% | — | ||
| Q4 24 | 19.3% | — | ||
| Q3 24 | 21.3% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 18.6% | — |
营业利润率ACARPRX
| Q4 25 | 11.0% | 62.4% | ||
| Q3 25 | 14.1% | 70.1% | ||
| Q2 25 | 12.9% | 36.3% | ||
| Q1 25 | 8.8% | 94.0% | ||
| Q4 24 | 6.5% | 60.9% | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 10.1% | 50.2% | ||
| Q1 24 | 8.9% | -13.0% |
净利率ACARPRX
| Q4 25 | 7.3% | 34.4% | ||
| Q3 25 | 9.2% | 47.3% | ||
| Q2 25 | 8.1% | 5.2% | ||
| Q1 25 | 3.7% | 41.9% | ||
| Q4 24 | -1.2% | 35.1% | ||
| Q3 24 | 2.6% | 96.3% | ||
| Q2 24 | 6.9% | 19.0% | ||
| Q1 24 | 6.5% | 0.8% |
每股收益（稀释后）ACARPRX
| Q4 25 | $1.06 | $0.49 | ||
| Q3 25 | $1.48 | $0.67 | ||
| Q2 25 | $1.22 | $0.07 | ||
| Q1 25 | $0.48 | $0.55 | ||
| Q4 24 | $-0.16 | $0.46 | ||
| Q3 24 | $0.34 | $1.21 | ||
| Q2 24 | $0.93 | $0.23 | ||
| Q1 24 | $0.80 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $214.6M | $618.7M |
| 总债务越低越好 | $1.5B | $9.0B |
| 股东权益账面价值 | $2.6B | $9.7B |
| 总资产 | $5.0B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.57× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ACARPRX
| Q4 25 | $214.6M | $618.7M | ||
| Q3 25 | $220.0M | $938.9M | ||
| Q2 25 | $189.7M | $631.9M | ||
| Q1 25 | $167.9M | $1.1B | ||
| Q4 24 | $187.3M | $929.0M | ||
| Q3 24 | $756.8M | $950.1M | ||
| Q2 24 | $103.7M | $1.8B | ||
| Q1 24 | $176.5M | $843.0M |
总债务ACARPRX
| Q4 25 | $1.5B | $9.0B | ||
| Q3 25 | $1.6B | $8.9B | ||
| Q2 25 | $1.7B | $8.0B | ||
| Q1 25 | $1.7B | $7.6B | ||
| Q4 24 | $1.7B | $7.6B | ||
| Q3 24 | $1.2B | $7.6B | ||
| Q2 24 | $699.9M | $7.6B | ||
| Q1 24 | $600.6M | $6.1B |
股东权益ACARPRX
| Q4 25 | $2.6B | $9.7B | ||
| Q3 25 | $2.6B | $9.6B | ||
| Q2 25 | $2.5B | $9.5B | ||
| Q1 25 | $2.5B | $9.8B | ||
| Q4 24 | $2.4B | $10.3B | ||
| Q3 24 | $2.4B | $10.3B | ||
| Q2 24 | $2.4B | $9.8B | ||
| Q1 24 | $2.4B | $9.9B |
总资产ACARPRX
| Q4 25 | $5.0B | $19.6B | ||
| Q3 25 | $5.1B | $19.3B | ||
| Q2 25 | $5.0B | $18.3B | ||
| Q1 25 | $4.9B | $17.6B | ||
| Q4 24 | $4.9B | $18.2B | ||
| Q3 24 | $4.4B | $18.0B | ||
| Q2 24 | $3.8B | $17.7B | ||
| Q1 24 | $3.7B | $16.1B |
负债/权益比ACARPRX
| Q4 25 | 0.57× | 0.92× | ||
| Q3 25 | 0.61× | 0.93× | ||
| Q2 25 | 0.67× | 0.84× | ||
| Q1 25 | 0.68× | 0.78× | ||
| Q4 24 | 0.69× | 0.74× | ||
| Q3 24 | 0.51× | 0.74× | ||
| Q2 24 | 0.29× | 0.78× | ||
| Q1 24 | 0.25× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $120.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $55.8M | — |
| 自由现金流率自由现金流/营收 | 7.8% | — |
| 资本支出强度资本支出/营收 | 9.0% | — |
| 现金转化率经营现金流/净利润 | 2.30× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $175.5M | — |
8季度趋势，按日历期对齐
经营现金流ACARPRX
| Q4 25 | $120.0M | $827.1M | ||
| Q3 25 | $160.6M | $702.6M | ||
| Q2 25 | $61.2M | $364.0M | ||
| Q1 25 | $-700.0K | $596.1M | ||
| Q4 24 | $248.2M | $742.5M | ||
| Q3 24 | $135.0M | $703.6M | ||
| Q2 24 | $38.3M | $658.2M | ||
| Q1 24 | $80.5M | $664.6M |
自由现金流ACARPRX
| Q4 25 | $55.8M | — | ||
| Q3 25 | $121.0M | — | ||
| Q2 25 | $33.4M | — | ||
| Q1 25 | $-34.7M | — | ||
| Q4 24 | $194.9M | — | ||
| Q3 24 | $100.6M | — | ||
| Q2 24 | $-9.3M | — | ||
| Q1 24 | $26.1M | — |
自由现金流率ACARPRX
| Q4 25 | 7.8% | — | ||
| Q3 25 | 15.2% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | -5.5% | — | ||
| Q4 24 | 29.3% | — | ||
| Q3 24 | 15.7% | — | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | 4.4% | — |
资本支出强度ACARPRX
| Q4 25 | 9.0% | — | ||
| Q3 25 | 5.0% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 7.2% | — | ||
| Q1 24 | 9.1% | — |
现金转化率ACARPRX
| Q4 25 | 2.30× | 3.86× | ||
| Q3 25 | 2.20× | 2.44× | ||
| Q2 25 | 1.03× | 12.06× | ||
| Q1 25 | -0.03× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 8.13× | 1.29× | ||
| Q2 24 | 0.84× | 6.45× | ||
| Q1 24 | 2.05× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACA
| Engineered Structures | $301.1M | 42% |
| Total Construction Materials | $276.8M | 39% |
| Specialty Materials And Asphalt | $110.2M | 15% |
| Construction Site Support | $28.6M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
